La Renon Healthcare Pvt Ltd
Ferric Carboxymaltose (50mg)
Larinject 50mg Injection is an iron replacement medicine used to treat iron-deficiency anemia, a type of anemia where you have fewer red blood cells due to insufficient iron in your body.
Injection
Larinject 50mg Injection is given by injection or infusion into a vein by your doctor or nurse. It is usually given in two doses seven days apart. Your doctor will decide how much and how often you may need injections to improve your anemia. Eating a well-balanced diet that has enough iron, vitamins, and minerals can help to replenish your iron reserves. Good sources of iron include meat, eggs, raisins, broccoli, and lentils.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Vomiting Headache Dizziness High blood pressure Pain or irritation at the site of injection
It is not known whether it is safe to consume alcohol with Larinject 50mg Injection. Please consult your doctor.
Larinject 50mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Larinject 50mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Larinject 50mg Injection is an anti-anemic medication that replenishes the iron stores in your body. Iron is vital for the formation of new red blood cells and hemoglobin, a substance that gives these cells the ability to transport oxygen.
Inform your doctor if you are taking any iron-containing products by mouth Do not consume alcohol when on treatment with this medicine as it may worsen its side effects It may cause your stools to become black or dark in color. This is normal and harmless Your blood pressure and blood iron levels will be regularly monitored during treatment with this medication
Larinject 50mg Injection should be administered by trained medical staff who can manage serious allergic reactions. It can be given undiluted into a vein, via a dialyzer for patients on dialysis, or diluted and infused into the vein. Monitor the patient for at least 30 minutes after each injection, and do not administer it subcutaneously or intramuscularly.
Larinject 50mg Injection vials should be stored between 20°C to 25°C (68°F to 77°F). Avoid freezing and keep the temperature within a range of 15°C to 30°C (59°F to 86°F) for optimal storage.
Two doses are typically given 7 days apart. Monitor hemoglobin levels at least 4 weeks after the final injection to allow for red blood cell formation and adjust treatment as needed based on individual requirements.
Yes, it may cause a temporary increase in blood pressure accompanied by facial flushing, dizziness, and nausea. These symptoms usually resolve within 30 minutes after administration.
If leakage occurs at the administration site, stop administration immediately to prevent skin irritation and long-lasting brown discoloration. Proper wound care is essential in such cases.
There is limited data on its use in pregnant women. If you become pregnant while taking Larinject 50mg Injection, consult your doctor immediately to discuss the risks and benefits of continuing treatment or discontinuing it.